Clinical Trial Update: Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine [Phase 3]

View source ↗

Summary

Phase III trial update for a tetravalent dengue vaccine evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• Tetravalent dengue vaccine

Snippet

Sponsor: Butantan Institute | Conditions: Dengue | Phase 3 | Status: UNKNOWN